Transformation of myrtenoic acid nitrile to aminophospholene oxide by the reaction with dibenzylphosphine oxide:: the X-ray structure of (1S*,2R*,6R*,8R*)-5-benzyl-9,9-dimethyl-5-oxo-4-phenyl-5-phosphatricyclo[6.1.1.02,6]dec-3-en-3-ylamine

被引：0
|
作者：
Kolesnik, VD
Rybalova, TV
Gatilov, YV
Tkachev, AV [1 ]
机构：
[1] Russian Acad Sci, Siberian Branch, NN Vorozhtsov Novosibirsk Inst Organ Chem, Novosibirsk 630090, Russia
[2] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia
来源：
MENDELEEV COMMUNICATIONS | 2001年 / 03期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The reaction of dibenzylphosphine oxide with myrtenoic acid nitrile in tert-butyl methyl ether in the presence of sodium hydride results in the formation of substituted aminophospholene oxide in good yield (83%).
引用
收藏
页码：98 / U3
页数：2
相关论文
共 50 条
  • [41] APPROACHES TO THE ASSEMBLY OF THE ANTIFUNGAL AGENT FR-900848 - STUDIES ON THE ASYMMETRIC-SYNTHESIS OF BICYCLOPROPANES AND AN X-RAY CRYSTALLOGRAPHIC ANALYSIS OF (4R,5R)-2-[(1R,3S,4S,6R)-6-PHENYL-1-BICYCLOPROPYL]-1,3-DIMETHYL-4,5-DIPHENYLIMIDAZOLIDINE (VOL 15, PG 1783, 1994)
    BARRETT, AGM
    DOUBLEDAY, WW
    TUSTIN, GJ
    WHITE, AJP
    WILLIAMS, DJ
    JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1994, (23) : 2739 - 2739
  • [42] Approaches to carbocyclic analogues of the potent neuraminidase inhibitor 4-guanidino Neu5Ac2en. X-Ray molecular structure of N-[(1S,2S,6R)-2-azido-6-benzyloxymethyl$M IN@4- formylcyclohex-3-enyl]acetamide
    J Chem Soc Perkin Trans 1, 9 (1189):
  • [43] Crystal structure of dimethyl (2R*,3R*,3aR*,4R*,5S*,6aR*)-3,5-butano-4-hydroxy-2-methoxy-1-oxa-6-oxo-perhydro-pentalene-3a,4-dicarboxylate, C11H12O2(OH)(OCH3)(COOCH3)2
    Peters, K
    Peters, EM
    Liebenau, M
    Tochtermann, W
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 1998, 213 (02): : 293 - 294
  • [44] Crystal structure of (1S,2R,3R,5aR,6S,7R,8R,10aR)-5,10-di-(tert-butoxycarbonyl)-3,8-di-(iodomethyl)-1,2:6,7-di-isopropylidenedioxy-perhydro-dipyrrolo[1,2-b:1,2-e]-1,2,4,5-tetrazine, C26H42I2N4O8
    Henkel, S
    Shaw, D
    Dong, HQ
    Jäger, V
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2001, 216 (04): : 613 - 615
  • [45] Crystal structure of [1R*,2S*,3R*(S),4S*]-α-oxo-3-(10-oxo-9-phenyl-bicyclo[6.2.9]-dec-1(8)-en-9-ylbicyclo[2.2.1]heptane-2-acetic acid methyl ester, C4O(C6H12)(C6H5)[C7H10(C3H3O3)]
    Peters, K
    Peters, EM
    Hegmann, J
    Christl, M
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 1998, 213 (04): : 765 - 766
  • [46] CRYSTAL-STRUCTURE OF TERT-BUTYL(-)-(1R-2S-5R-7R-8S-4'S)-2-BENZYLOXY-8-(2',2'-DIMETHYL-1',3'-DIOXOLAN-4'-YL)-6-OXO-TRICYCLO[3.2.1.0(2.7)]OCTANE-1-CARBOXYLATE, C25H32O6
    PETERS, K
    PETERS, EM
    VONSCHNERING, HG
    BRAUN, NA
    KLEIN, I
    SPITZNER, D
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE, 1995, 210 (06): : 453 - 454
  • [47] Crystal structure of (1S,8R)-8,11,11-trimethyl-3-methylsulfanyl-5-oxo-4-thiatricyclo[6.2.1.02,7]undeca-2,6-dien-6-carbonitrile, C15H17NOS2
    Kempe, R
    Lalk, M
    Peseke, K
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 1998, 213 (03): : 625 - 626
  • [48] Crystal structure of (1S,2R,3S,4S,5R)-7-benzyl-2,3-O-isopropylidene-6-oxa-7-aza-bicyclo[3.2.1]octan-2,3,4-triol, C16H21NO4
    Gültekin, Z
    Frey, W
    Jäger, V
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2002, 217 (02): : 283 - 284
  • [49] Crystal structure of (2R,3R,5R,6R)-5,6-bis(diphenylphosphanyl)methyl)-2,3-diethoxy-2,3-dimethyl[1,4]dioxane rhodium(I)-(Z,Z)-cycloocta-1,5-diene tetrafluoroborate, C88H108B2F8O8P4Rh2
    Kempe, R
    Spannenberg, A
    Heller, D
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 1998, 213 (03): : 633 - 635
  • [50] Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371•HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like Activity
    Chappell, Mark D.
    Li, Renhua
    Smith, Stephon C.
    Dressman, Bruce A.
    Tromiczak, Eric G.
    Tripp, Allie E.
    Blanco, Maria-Jesus
    Vetman, Tatiana
    Quimby, Steven J.
    Matt, James
    Britton, Thomas C.
    Fivush, Adam M.
    Schkeryantz, Jeffrey M.
    Mayhugh, Daniel
    Erickson, Jon A.
    Bures, Mark G.
    Jaramillo, Carlos
    Carpintero, Mercedes
    Eugenio de Diego, Jose
    Barberis, Mario
    Garcia-Cerrada, Susana
    Soriano, Jose F.
    Antonysamy, Stephen
    Atwell, Shane
    MacEwan, Lain
    Condon, Bradley
    Sougias, Christine
    Wang, Jing
    Zhang, Aiping
    Conners, Kris
    Groshong, Chris
    Wasserman, Stephen R.
    Koss, John W.
    Witkin, Jeffrey M.
    Li, Xia
    Overshiner, Carl
    Wafford, Keith A.
    Seidel, Wesley
    Wang, Xu-Shan
    Heinz, Beverly A.
    Swanson, Steven
    Catlow, John T.
    Bedwell, David W.
    Monn, James A.
    Mitch, Charles H.
    Ornstein, Paul L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (24) : 10974 - 10993
12345